Rising Adoption Of Personalized Therapies Driving The Market Growth Due To Advances In Genomic Technologies And Targeted Treatment Approaches Is Supporting Development Across The Precision Oncology Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Precision Oncology Market Projected To Expand During 2026–2030?

The precision oncology market has seen rapid expansion in recent years. Its valuation is expected to climb from $106.21 billion in 2025 to $117.67 billion in 2026, indicating a compound annual growth rate (CAGR) of 10.8%. The historical growth of this market can be attributed to the limited availability of genomic sequencing technologies, a reliance on conventional chemotherapy, increasing cancer prevalence globally, the early adoption of immunotherapy, and burgeoning research in molecular oncology.

The precision oncology market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $175.38 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. The expansion during the forecast period can be attributed to the advancement of next-generation sequencing platforms, the increasing integration of bioinformatics and artificial intelligence in oncology, the rising adoption of liquid biopsy and molecular imaging, the broadening of personalized treatment alternatives, and the growth of research partnerships between hospitals and pharmaceutical enterprises. Significant trends in the forecast period include the broadening of targeted cancer therapies based on molecular profiling, the increasing embrace of liquid biopsy and non-invasive diagnostic methodologies, an increase in biomarker-based testing for individualized treatment plans, the escalating integration of immunotherapy with genomic sequencing, and a heightened focus on rare and difficult-to-treat cancer varieties.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

Which Drivers Are Advancing The Precision Oncology Market Growth?

The growing understanding and transition towards tailored treatments are projected to fuel the expansion of the precision oncology market moving forward. Tailored treatments are therapeutic approaches customized to an individual’s genetic makeup, biological markers, and specific disease characteristics, designed to enhance efficacy and mitigate side effects. The rise in personalized therapies stems from breakthroughs in genomic technologies, which facilitate the precise identification of disease-causing mutations, enabling more potent and focused interventions. Precision oncology advances personalized therapies through the application of genomic and molecular profiling to customize cancer treatment according to the specific genetic composition of a patient’s tumor. As an illustration, in February 2023, GOV.UK, a government department based in the UK, announced that the Health and Social Care Secretary signed a Memorandum of Understanding with BioNTech SE to accelerate cancer vaccine research in England, with a goal of delivering 10,000 personalized therapy doses to UK patients by 2030. Hence, the increasing awareness and adoption of personalized therapies are driving the growth of the precision oncology market.

How Is The Precision Oncology Market Examined Through Segment Analysis?

The precision oncology market covered in this report is segmented –

1) By Type: Genomic Sequencing, Immunotherapy

2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

Which Trends Are Guiding The Development Of The Precision Oncology Market?

Companies operating in the precision oncology market are prioritizing the development of innovative strategies, such as the molecular tumor board, to support personalized treatment decisions by integrating genomic information with clinical context. A molecular tumor board represents a dedicated group of specialists who analyze and interpret complex genomic and molecular test data to guide precision-driven cancer therapies, specifically tailored to the unique tumor characteristics of individual patients. For instance, in December 2024, Aster DM Healthcare Ltd., a UAE-based healthcare provider, introduced a precision oncology clinic as one of three personalized cancer care initiatives designed to transform treatment through data-driven, genomic-focused strategies. This clinic delivers customized cancer therapy based on each patient’s tumor genetic profile, enabling more precise, effective treatments with reduced side effects. This approach enhances treatment outcomes, minimizes toxicity, and improves quality of life by aligning therapies with the unique molecular features of a patient’s cancer.

Which Key Players Are Active In The Precision Oncology Market?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Access The Complete Precision Oncology Market Report:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Geographic Region Represents The Largest Precision Oncology Market Share?

North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Precision Oncology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2026, By The Business Research Company

Precast Concrete Market 2026

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Boiler Tank And Shipping Container Market Report 2026

https://www.thebusinessresearchcompany.com/report/boiler-tank-and-shipping-container-global-market-report

Drill Pipe Market Report 2026

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795